Skip to main content
. 2019 Sep 12;30(10):1939–1951. doi: 10.1681/ASN.2019050462

Table 2.

Allograft outcomes after kidney transplantation

Variable Comparing Outcomes after Transplanting HCV-Viremic Kidneys Versus HCV-Nonviremic Kidneys into HCV-Seronegative Recipients Comparing Outcomes for Recipients of HCV-Viremic Kidneys When Transplanted into HCV-Seronegative Versus HCV-Seropositive Recipientsa
HCV NAT D+/R−, n=103 Matched Comparators HCV NAT D−/R−, n=206 P Valueb HCV NAT D+/R−, n=102 Matched Comparators HCV NAT D+/R+, n=204 P Valueb
Delayed graft function, N (%) 20 (19.6%) 22 (11%) 0.05 20 (19.9%) 33 (16.4%) 0.44
Acute rejection, N (%) 4 (3.9%) 11 (5.4%) 0.57 4 (3.9%) 13 (6.3%) 0.38
Graft failed but recipient alive, N (%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Died, N (%) 0 (0%) 6 (2.9%) 0 (0%) 7 (3.4%)
No. analyzedc n=101 n=190 n=100 n=193
6-mo creatinine, mg/dl, mean (SD) 1.26 (0.31) 1.27 (0.36) 0.73 1.26 (0.31) 1.22 (0.39) <0.01
6-mo eGFR, ml/min per 1.73 m2, mean (SD) 66.3 (17.4) 66.4 (17.5) 0.41 66.4 (17.4) 70.1 (17.7) 0.02
No. analyzedd n=93 n=173 n=94 n=173
12-mo creatinine, mg/dl, mean (SD) 1.26 (0.34) 1.29 (0.49) 0.33 1.26 (0.35) 1.2 (0.37) 0.01
12-mo eGFR, ml/min/1.73 m2, mean (SD) 66.3 (18.7) 67.1 (22.5) 0.86 66.5 (18.8) 71.1 (18.9) 0.06

HCV, hepatitis C virus; NAT, nucleic acid test; —, P values were not computed.

a

We found matches for 102 of 103 patients.

b

P values were computed using STATA vanelteren test for continuous outcomes and conditional logistic regression for binary outcomes. Due to low anticipated event rate we did not compute P values for the following variables: graft failed but recipient alive; and died.

c

Pairs were excluded from analysis when patients did not have 6-month creatinine values; also, pairs were excluded in which two of two comparators lacked 6-month follow-up creatinine.

d

Pairs were excluded from analysis when patients did not have 12-month creatinine values; also, pairs were excluded in which two of two comparators lacked 12-month follow-up creatinine.